Be part of
improving Cancer treatment

CYTO365 is improving the Cancer treatments with RondelO™ IV-set. Help us spread the word — every share matters.

RondelO™ IV-set reduce the risk of drug mixing, and avoids exposure risk for the nurses.

RondelO™ IV-set is regarded as the "Golden Standard" - However, a new standard takes time to implement and it requires dedicated investors time and funding. Make a difference!

Everyone knows someone that have been treated for Cancer - lets help the nurses to help the patients.

Get company updates and investor-related news

CYTO365 A1001-01
ART NO. A1001-01
Avoid drug mixing by Design

How it works

01
Join the update list

Name + email. Get set up in 10 seconds.

02
Become an ambassador

Show your QR, spread the word, climb the leaderboard.

03
Stay informed